ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neurotrauma

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1561177

The ROX@PDA@PCL vascularized bionic nerve conduit facilitates the restoration of nerve defects

Provisionally accepted
  • 1China-Japan Friendship Hospital, Beijing, Beijing Municipality, China
  • 2The ninth Medical Center of Chinese PLA General Hospital, Beijing, China
  • 3Peking University People's Hospital, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

Previous research has highlighted the pivotal role of angiogenesis in facilitating nerve function repair following nerve injury. In this study, we employed polydopamine (PDA) to modify polycaprolactone (PCL) and subsequently loaded it with Roxadustat (ROX), thereby constructing a vascularized nerve conduit for the repair of a 10 mm sciatic nerve defect in rats. At 2 weeks post-surgery, new blood vessels were evaluated by immunofluorescence staining. Twelve weeks post-surgery, a comprehensive suite of assessments was conducted to evaluate the efficacy of the conduit, including gait analysis, determination of gastrocnemius muscle wet weight recovery, electrophysiological examination of gastrocnemius compound action potential(CMAP), Masson staining to evaluate gastrocnemius muscle fiber crosssectional area, toluidine blue staining to assess the total number of regenerated myelinated nerve fibers, and electron microscopic observation of myelin sheath thickness. Our findings revealed that ROX@PDA@PCL could promote the proliferation of vascular endothelial cells and significantly enhance angiogenesis in regenerated nerves (P < 0.05). Regarding the recovery of neurological function, compared to the PDA@PCL and PCL groups, the ROX@PDA@PCL group exhibited significantly superior outcomes in the sciatic functional index (SFI), CMAP, gastrocnemius muscle wet weight ratio, muscle fiber cross-sectional area, total number of regenerated myelinated nerve fibers, and myelin sheath thickness. These indices approached those of the autologous group, but were still lower than in the autograft group (p < 0.05). The study underscores the potential of the vascularized nerve graft (ROX@PDA@PCL), constructed through PDA-mediated loading of ROX onto PCL, to enhance functional nerve recovery. Our findings present a promising new therapeutic approach for the clinical repair of peripheral nerve defects.

Keywords: roxadustat, Nerve defect, nerve conduit, vascularization, Neurological function

Received: 15 Jan 2025; Accepted: 24 Apr 2025.

Copyright: © 2025 Lin, Peng, Zhang, Wang, Xu and Jia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xiaoping Wang, The ninth Medical Center of Chinese PLA General Hospital, Beijing, China
Xiaodong Xu, China-Japan Friendship Hospital, Beijing, 100029, Beijing Municipality, China
Jing Jia, The ninth Medical Center of Chinese PLA General Hospital, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.